Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by von Minckwitz Gunter
PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
Related publications
A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer
Tumor Biology
Medicine
Cancer Research
Polymorphisms in AURKA and AURKB Are Associated With the Survival of Triple-Negative Breast Cancer Patients Treated With Taxane-Based Adjuvant Chemotherapy
Cancer Management and Research
Oncology
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Clinical Cancer Research
Cancer Research
Oncology
Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane in Triple Negative Breast Cancer: Results From the HOPE Study
PLoS ONE
Multidisciplinary
Association of Pretreatment Anemia With Pathological Response and Survival of Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Population-Based Study
PLoS ONE
Multidisciplinary
Evolving Approaches to Metastatic Breast Cancer Patients Pre-Treated With Anthracycline and Taxane
BioDrugs
Medicine
Biotechnology
Pharmacology
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
